Screening of accumulation of biologically active substances of Iris hungarica during vegetation period

Authors

  • A. V. Krechun National University of Pharmacy, Kharkiv, Ukraine,
  • O. O. Mykhailenko National University of Pharmacy, Kharkiv, Ukraine,
  • S. V. Kovalov National University of Pharmacy, Kharkiv, Ukraine,
  • T. H. Orlova Botanical Garden V. N. Karazin, Kharkiv, Ukraine,

DOI:

https://doi.org/10.14739/2409-2932.2019.2.170975

Keywords:

iris, biologically active substances, medical plants, biostatistics

Abstract

 

Establishing of accumulation dynamics of various groups of biologically active substances (BAS) in plants has great importance for obtaining high-quality raw materials.

The aim of the work: to establish the quantitative content of biologically active substances groups in Iris hungarica raw materials during the growing season, harvested in different regions of Ukraine.

Materials and methods: a preliminary analysis was performed using paper chromatography. The quantitative content of the main groups of biologically active substances (hydroxycinnamic acids, flavonoids, isoflavones, xanthones) was determined by spectrophotometry.

Results: the quantitative content of hydroxycinnamic acids (2.66–7.44 %), flavonoids (2.12–3.04 %), isoflavonoids (1.03–1.79 %), xanthones (1.24–1.72 %) was established in the studied samples. The accumulation of biologically active substances occurs more intensively during the spring growing season of Iris hungarica, only isoflavonoids accumulate more actively in the autumn, which is associated with the peculiarities of the synthesis and accumulation of secondary metabolites of this plant. It was noted, that in the elevated part of the Iris hungarica, the accumulation of such BAS groups as hydroxycinnamic acids, flavonoids and xanthones occurs more intensively. The highest content of isoflavones is observed in underground organs in comparison with the sprout.

Conclusions: a qualitative and quantitative analysis of leaves and rhizomes of Iris hungarica, harvested in different vegetation periods in several regions of Ukraine, has been carried out. According to the results of the analysis, it is possible to conclude, that harvesting of Iris hungarica leaves is more rational in the spring vegetation period, and the rhizome - as a source of isoflavones - in the autumn, since the content of biologically active substances in the raw material is currently higher.

 

 

References

Xu, Z. & Chang, L. (2017). Iridaceae. In Identification and Control of Common Weeds. Springer, 3, 905–908. doi: https://doi.org/10.1007/978-981-10-5403-7_37

Kaššák, P. (2014). Screening of the chemical content of several Limniris group Irises. Journal of Pharmacognosy and Phytochemistry, 3(2), 11–14.

Ullah, F., Ayaz, M., Sadiq, A., Hussain, A., Ahmad, S., Imran, M., & Zeb, A. (2016). Phenolic, flavonoid contents, anticholinesterase and antioxidant evaluation of Iris germanica var; florentina. Natural product research, 30(12), 1440–1444. doi: 10.1080/14786419.2015.1057585

Mir, A. H. (2014). Pharmacological and phytochemical properties of Iris kashmiriana baker as a potential medicinal plant of Kashmir Himalaya. Global Journal of Research on Medicinal Plants & Indigenous Medicine, 3(12), 460.

Basgedik, B., Ugur, A., & Sarac, N. (2014). Antimicrobial, antioxidant, antimutagenic activities, and phenolic compounds of Iris germanica. Industrial Crops and Products, 61, 526–530. doi: 10.1016/j.indcrop.2014.07.022

Kukula-Koch, W., Sieniawska, E., Widelski, J., Urjin, O., Głowniak, P., & Skalicka-Woźniak, K. (2015). Major secondary metabolites of Iris spp. Phytochemistry reviews, 14(1), 51–80. doi: 10.1007/s11101-013-9333-1

Jang, J. H., Lee, K. H., Jung, H. K., Sim, M. O., Kim, T. M., Woo, K. W., et al. (2016). Anti-inflammatory effects of 6′-O-acetyl mangiferin from Iris rossii Baker via NF-κb signal blocking in lipopolysaccharide-stimulated RAW 264.7 cells. Chemico-biological interactions, 257, 54–60. doi: 10.1016/j.cbi.2016.07.029

Alam, A., Jaiswal, V., Akhtar, S., Jayashree, B. S., & Dhar, K. L. (2017). Isolation of isoflavones from Iris kashmiriana Baker as potential anti proliferative agents targeting NF-kappa B. Phytochemistry, 136, 70–80. doi: 10.1016/j.phytochem.2017.01.002

Wang, H., Cui, Y., & Zhao, C. (2010). Flavonoids of the genus Iris (Iridaceae). Mini reviews in medicinal chemistry, 10(7), 643–661. doi: 10.2174/138955710791384027

Marinescu, V. M. & Alexiu, V. (2013). Iris aphylla L. ssp. hungarica critically endangered taxon in Europa. Current Trends in Natural Sciences, 2(3), 96–99.

(2008) Derzhavna Farmakopeia Ukrainy [State Pharmacopoeia of Ukraine, State Enterprise: Scientific and Expert Pharmacopoeial Centre]. Kharkiv. [in Ukrainian].

Belikov, V. V., & Schreiber, M. S. (1970). Metody analiza flavonoidnykh soedinenij [Methods of analysis of flavonoid compounds]. Farmaciya, 19(1), 66–72. [in Russian].

(2008) Derzhavna Farmakopeia Ukrainy [State Pharmacopoeia of Ukraine, State Enterprise: Scientific and Expert Pharmacopoeial Centre]. Kharkiv. [in Ukrainian].

Aslanukov, A. K., Airapetova, A. Yu., & Serebryannaya, F. K. (2009) Identifikaciya i kolichestvennoe opredelenie summy ksantonov v pereschete na mangiferin v trave kopeechnika kavkazskogo (Hedysarum caucasicum Bieb.) [Identification and quantitative determination of the amount of xanthones in terms of mangiferin in the herb of Hedysarum caucasicum Bieb.] Razrabotka, issledovanie i marketing novoj farmacevticheskoj produkcii, 64. Pyatigorsk. [in Russian].

Bazarnova, N. G., Il'ichyova, T. N., Tikhomirova, L. I., & Sinicina, A. A. (2016). Skrining khimicheskogo sostava i biologicheskoj aktivnosti Iris sibirica L. sort Cambridge. [Screening of the chemical composition and biological activity of Iris sibirica L.,Cambridge variety]. Khimiya rastitel'nogo syr'ya, 3, 49–57. [in Russian]. doi: https://doi.org/10.14258/jcprm.2016031227

Downloads

How to Cite

1.
Krechun AV, Mykhailenko OO, Kovalov SV, Orlova TH. Screening of accumulation of biologically active substances of Iris hungarica during vegetation period. Current issues in pharmacy and medicine: science and practice [Internet]. 2019Jun.24 [cited 2024Apr.24];(2). Available from: http://pharmed.zsmu.edu.ua/article/view/170975

Issue

No. 2 (2019)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.     Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)